August 30, 2026 — RNews

#oligonucleotides — Sunday, August 30, 2026 (1 items)

hot top new

← prev day next day →

0

Eplontersen with and without background transthyretin stabilizers in transthyretin amyloid cardiomyopathy: secondary analysis of a phase 3, randomized controlled trial. (nature.com)

Garcia-Pavia P … Maurer MS Nature Medicine 2026-08-30

#amyloid #cardiomyopathy #therapeutics #oligonucleotides #cardiology